Meet the experienced team behind our innovative patch ECG monitor

Dr. Bardy has been a cardiac electrophysiologist since 1983 with research interests in cardiac defibrillator technology, cardiac arrest, ablation, heart failure and atrial fibrillation from both a public health and a technical perspective. He has been a researcher and clinician in the field of sudden death and disabling cardiac rhythm disorders for 38 years with over 400 peer-reviewed publications. Dr. Bardy has also developed technological solutions to patient rhythm problems with over 270 U.S. patents issued, all of which have been incorporated in cardiac rhythm management technologies in use by many medical device companies. Most recently, Dr. Bardy’s previous company, Cameron Health, was successfully acquired by Boston Scientific in 2012 for its revolutionary Subcutaneous Implantable Defibrillator (S-ICD) product. In addition to serving Bardy Diagnostics, Dr. Bardy holds a faculty position as Clinical Professor of Medicine, Cardiology at the University of Washington and is the Director of the Seattle Institute for Cardiac Research. Dr. Bardy earned a BS in physics from Carnegie-Mellon University before completing his MD from Northwestern University Medical School. In addition, he completed his residency at Northwestern University and a fellowship in cardiology and electrophysiology at Duke University.

Mark has more than twenty years of experience in the medical device industry in a wide variety of roles. Most recently, Mark was Vice President and Chief Financial Officer for Calypso Medical Technologies, Inc., a pioneer in electromagnetic guidance technology used in conjunction with radiation therapy for prostate cancer and other solid tumors. While at Calypso, Mark helped to build out the team, raise capital, implement its reimbursement strategy, and develop leasing solutions for its customers. Prior to Calypso, Mark served as Director of Finance at EKOS Corporation, which developed a unique ultrasound-enabled drug delivery system for treating peripheral blood vessel occlusions. Mark also served as Finance Manager for Abbott Laboratories where he helped establish operating companies in several Eastern European countries. He began his career as an audit professional with Price Waterhouse. Mark earned a B.A. in English and Accounting from Hillsdale College.

For the last 18 years, Ed worked in medical technology for radiation oncology monitoring and therapeutics – including CEO of Calypso Medical Systems acquired by Varian Medical Systems. Most recently at Varian, Ed was Vice President Global Portfolio Solutions, responsible for managing the $2.3B portfolio of linear accelerator systems and accessories, brachytherapy, strategic initiatives, global strategic customer and commercial partnerships, product marketing and strategic marketing. In prior years, Ed has held numerous leadership positions managing R&D and Operations at Palm, development of the PalmPilot, Palm III and Palm VII product lines, and prior to that as Chief Scientist of Boeing’s Phased Array Systems Organization.

Brit has more than 23 years of experience in the medical device industry. After spending a decade focusing on manufacturing engineering and product development, he transitioned to regulatory affairs and quality assurance, including roles at Boston Scientific, Pathway Medical (acquired by Bayer Healthcare), and two tours at EKOS Corporation (acquired by BTG). This background has resulted in the launching of a broad spectrum of products to market, from simple guidewires to complex hardware and software systems with varied clinical applications. Brit earned a B.S. in Industrial Engineering and an M.B.A from the University of Washington.

With over 17 years in the medical device industry, Bobby brings extensive experience in structuring, optimizing, and deploying sales assets from companies of varying sizes from early and late stage start-ups to large-scale businesses. Prior to joining Bardy Diagnostics, Cockrill served as Vice President of Sales at SonoSim, Inc., where he was tasked with reengineering and growing the sales team. In addition, he possesses strong experience in the cardiac device space with various sales leadership positions at Boston Scientific, Cardionet (now BioTelemetry), and Eli Lilly and Company. Bobby graduated from the University of Richmond with dual degrees in Leadership Studies and Rhetoric & Speech Communication. He earned an M.B.A. from the University of Southern California Marshall School of Business.

He brings a strong record of leading successful product development efforts, building strong Engineering teams, and championing continuous improvement in the medical device domain in both startup and large company environments, domestic and international. Chuck’s experience includes leading development efforts at Calypso Medical Technologies (Radiation Therapy Localization Systems), Siemens Medical Systems (Diagnostic Ultrasound), and Confirma (MRI Image Processing). Chuck earned a B.S. in Electrical Engineering from the University of Colorado.

With over 20 years of sales and marketing experience within the healthcare industry, Cristina brings extensive experience to the Bardy team in the diagnostic cardiac patch monitoring space. In her 6 years at iRhythm Technologies as their first commercial-facing employee, Cristina built the Marketing team and oversaw all the marketing, sales training, and new markets activities, including the launch of their flagship product, the Zio Patch. Most recently, Cristina was in charge of market development and sales for the Long-Term Care market at the health technology company MedBridge. She has held several other leadership roles at various companies within the medical device industry, including Cordis Cardiology (Cardinal Health) and FoxHollow Technologies (Medtronic). She started her career in pharmaceutical sales, receiving several national awards during her tenure at both Parke-Davis and Wyeth. Cristina holds an MBA from the Wharton School at the University of Pennsylvania and a BA from Haverford College.

With over 30 years of experience in manufacturing (23 years specific to the medical device industry), Corey brings with him a vast array of best practices from start-ups, large organizations, and contract manufacturers.  Most recently, Corey was Director at Spiration (a division of Olympus Medical) overseeing the manufacturing of a Class III medical device for the treatment of Emphysema and Chronic Air Leaks. Prior to that, Corey honed his operational skills at Chatham Technologies (in the Telecom industry and acquired by Flextronics), SeaMed (contract medical device manufacturer), Siemens Medical Systems (diagnostic ultrasound), and Fluke (electronic test and measurement equipment). Corey earned a B.S. in Industrial Engineering from the University of Washington.

With almost 20 years of experience working in Cardiology and Electrophysiology, Liz provides an expertise in cardiac monitoring that encompasses both the clinic and corporate setting. She worked in various roles in the cardiac rhythm management industry for Biotronik and Medtronic, including the successful launch and sales growth of Medtronic’s ICM device. Prior to joining BardyDx, she served as Clinical Director for a cardiac monitoring start-up that was acquired by Bardy Diagnostics, where she transitioned to Sr. Director, Clinical Services. Liz earned a B.S. degree in Exercise Physiology from Texas A&M University.

With more than 25 years of experience leading software teams in the medical device and healthcare software industries, Joe brings extensive knowledge of best practices for software development in regulated environments. Most recently, Joe led product development and information technology for the Owl Insights SaaS based behavioral health platform as the VP of Product Development. Joe’s roles have included strategic initiatives as well as leading software development and information technology teams in multi-national organizations and startup companies including Varian Medical Systems, Calypso Medical Technologies, Pluris Inc., Philips Medical Systems, and Acuson Corporation. Joe earned his B.S. degree in Computer Science from the University of Maryland.